Trial Profile
A prospective observational study evaluating effect of Idelalisib on platelet function in patients with chronic lymphocytic leukemia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Feb 2017
Price :
$35
*
At a glance
- Drugs Idelalisib (Primary)
- Indications Chronic lymphocytic leukaemia
- Focus Therapeutic Use
- 09 Feb 2017 New trial record